Kappa opioid receptor ligands

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S277000, C514S279000, C514S338000, C514S411000

Reexamination Certificate

active

07872023

ABSTRACT:
Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.

REFERENCES:
patent: 4891379 (1990-01-01), Zimmerman et al.
patent: 5128118 (1992-07-01), Carroll et al.
patent: 5141959 (1992-08-01), Carroll et al.
patent: 5298499 (1994-03-01), Carroll et al.
patent: 5380848 (1995-01-01), Kuhar et al.
patent: 5413779 (1995-05-01), Kuhar et al.
patent: 5457208 (1995-10-01), Portoghese et al.
patent: 5496953 (1996-03-01), Kuhar et al.
patent: 5736123 (1998-04-01), Carroll
patent: 5831095 (1998-11-01), Gonzalez et al.
patent: 5935953 (1999-08-01), Kuhar et al.
patent: 6123917 (2000-09-01), Carroll
patent: 6329520 (2001-12-01), Carroll et al.
patent: 6358492 (2002-03-01), Kuhar et al.
patent: 6416735 (2002-07-01), Carroll et al.
patent: 6479509 (2002-11-01), Carroll
patent: 6531481 (2003-03-01), Carroll et al.
patent: 6531483 (2003-03-01), Kuhar et al.
patent: 6538010 (2003-03-01), Carroll
patent: 6552032 (2003-04-01), Carroll et al.
patent: 6559159 (2003-05-01), Carroll et al.
patent: 6593348 (2003-07-01), Carroll et al.
patent: 6706880 (2004-03-01), Carroll et al.
patent: 2002/0132828 (2002-09-01), Carroll et al.
patent: 2002/0188003 (2002-12-01), Kuhar et al.
patent: 2003/0158415 (2003-08-01), Carroll et al.
patent: 2003/0176434 (2003-09-01), Carroll
patent: 2003/0203934 (2003-10-01), Kuhar et al.
patent: 2004/0146518 (2004-07-01), Carroll et al.
patent: WO 02/053533 (2002-07-01), None
patent: WO 2004/082623 (2004-09-01), None
Carroll, “Pharmacological properties of JDTic: a novel n-opioid receptor antagonist”, European Journal of Pharmacology, 2004, 501, pp. 111-119.
U.S. Appl. No. 11/272,492, filed Nov. 14, 2005, Carroll.
U.S. Appl. No. 12/105,814, filed Apr. 18, 2008, Carroll, et al.
U.S. Appl. No. 09/623,872, filed Oct. 17, 2000, Carroll et al.
U.S. Appl. No. 11/189,068, filed Jul. 26, 2005, Carroll et al.
U.S. Appl. No. 11/113,158, filed Apr. 25, 2005, Carroll et al.
U.S. Appl. No. 10/986,352, filed Nov. 12, 2004, Kuhar et al.
U.S. Appl. No. 10/259,780, filed Sep. 30, 2002, Carroll et al.
U.S. Appl. No. 09/537,668, filed Mar. 29, 2000, Carroll et al.
U.S. Appl. No. 60/107,902, filed Nov. 10, 1998, Carroll.
U.S. Appl. No. 08/701,503, filed Aug. 22, 1996, Boja et al.
U.S. Appl. No. 08/506,541, filed Jul. 24, 1995, Kuhar et al.
U.S. Appl. No. 11/863,587, filed Sep. 28, 2007, Kuhar et al.
U.S. Appl. No. 12/551,072, filed Aug. 31, 2009, Carroll.
Australian Office Action issued Sep. 20, 2010, in Application Serial No. 2006214118.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Kappa opioid receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kappa opioid receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa opioid receptor ligands will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2730033

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.